154 related articles for article (PubMed ID: 25005845)
21. NAT2 and CYP1A2 polymorphisms and lung cancer risk in relation to smoking status.
Osawa Y; Osawa KK; Miyaishi A; Higuchi M; Tsutou A; Matsumura S; Tabuchi Y; Tsubota N; Takahashi J
Asian Pac J Cancer Prev; 2007; 8(1):103-8. PubMed ID: 17477782
[TBL] [Abstract][Full Text] [Related]
22. NAT2 polymorphism and lung cancer risk: a meta-analysis.
Cui D; Wang Z; Zhao E; Ma J; Lu W
Lung Cancer; 2011 Aug; 73(2):153-7. PubMed ID: 21292342
[TBL] [Abstract][Full Text] [Related]
23. NAT2 slow acetylator genotype is associated with increased risk of lung cancer among non-smoking Chinese women in Singapore.
Seow A; Zhao B; Poh WT; Teh M; Eng P; Wang YT; Tan WC; Lee EJ; Lee HP
Carcinogenesis; 1999 Sep; 20(9):1877-81. PubMed ID: 10469638
[TBL] [Abstract][Full Text] [Related]
24. Analysis of associations of NAT2 gene polymorphisms with the risk of lung cancer.
Nikishina MV; Vavilin VA; Makarova SI; Lyakhovich VV
Bull Exp Biol Med; 2007 Jan; 143(1):83-6. PubMed ID: 18019020
[TBL] [Abstract][Full Text] [Related]
25. Active cigarette smoking and the risk of breast cancer at the level of N-acetyltransferase 2 (NAT2) gene polymorphisms.
Kasajova P; Holubekova V; Mendelova A; Lasabova Z; Zubor P; Kudela E; Biskupska-Bodova K; Danko J
Tumour Biol; 2016 Jun; 37(6):7929-37. PubMed ID: 26700672
[TBL] [Abstract][Full Text] [Related]
26. Association of N-acetyltransferase-2 and glutathione S-transferase polymorphisms with idiopathic male infertility in Vietnam male subjects.
Trang NT; Huyen VT; Tuan NT; Phan TD
Chem Biol Interact; 2018 Apr; 286():11-16. PubMed ID: 29505746
[TBL] [Abstract][Full Text] [Related]
27. Differential interactions between GSTM1 and NAT2 genotypes on aromatic DNA adduct level and HPRT mutant frequency in lung cancer patients and population controls.
Hou SM; Fält S; Yang K; Nyberg F; Pershagen G; Hemminki K; Lambert B
Cancer Epidemiol Biomarkers Prev; 2001 Feb; 10(2):133-40. PubMed ID: 11219770
[TBL] [Abstract][Full Text] [Related]
28. Cytochrome P450 (CYP) 1A2, sulfotransferase (SULT) 1A1, and N-acetyltransferase (NAT) 2 polymorphisms and susceptibility to urothelial cancer.
Tsukino H; Kuroda Y; Nakao H; Imai H; Inatomi H; Osada Y; Katoh T
J Cancer Res Clin Oncol; 2004 Feb; 130(2):99-106. PubMed ID: 14648207
[TBL] [Abstract][Full Text] [Related]
29. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
Okkels H; Sigsgaard T; Wolf H; Autrup H
Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426
[TBL] [Abstract][Full Text] [Related]
30. [Relationship between polymorphism of N-acetyltransferase 2 and genetic susceptibility to laryngeal carcinoma].
Lei D; Pan X; Guo C; Xu F; Zhang L; Liu D; Luan X
Zhonghua Zhong Liu Za Zhi; 2002 Mar; 24(2):154-6. PubMed ID: 12015038
[TBL] [Abstract][Full Text] [Related]
31. GSTM1 and NAT2 polymorphisms in operable and non-operable lung cancer patients.
Hou SM; Ryberg D; Fält S; Deverill A; Tefre T; Børresen AL; Haugen A; Lambert B
Carcinogenesis; 2000 Jan; 21(1):49-54. PubMed ID: 10607733
[TBL] [Abstract][Full Text] [Related]
32. The role of NAT2 polymorphism and methylation in anti-tuberculosis drug-induced liver injury in Mongolian tuberculosis patients.
Zhang D; Hao J; Hou R; Yu Y; Hu B; Wei L
J Clin Pharm Ther; 2020 Jun; 45(3):561-569. PubMed ID: 32364660
[TBL] [Abstract][Full Text] [Related]
33. Association of CYP1A1, CYP1A2, GSTM1 and NAT2 gene polymorphisms with colorectal cancer and smoking.
Yoshida K; Osawa K; Kasahara M; Miyaishi A; Nakanishi K; Hayamizu S; Osawa Y; Tsutou A; Tabuchi Y; Shimada E; Tanaka K; Yamamoto M; Takahashi J
Asian Pac J Cancer Prev; 2007; 8(3):438-44. PubMed ID: 18159984
[TBL] [Abstract][Full Text] [Related]
34. N-acetyltransferase 2 polymorphism and breast cancer risk with smoking: a case control study in Japanese women.
Hara A; Taira N; Mizoo T; Nishiyama K; Nogami T; Iwamoto T; Motoki T; Shien T; Matsuoka J; Doihara H; Ishihara S; Kawai H; Kawasaki K; Ishibe Y; Ogasawara Y; Miyoshi S
Breast Cancer; 2017 Mar; 24(2):254-262. PubMed ID: 27068825
[TBL] [Abstract][Full Text] [Related]
35. N-acetyltransferase 1 and 2 polymorphisms and risk of diabetes mellitus type 2 in a Saudi population.
Al-Shaqha WM; Alkharfy KM; Al-Daghri NM; Mohammed AK
Ann Saudi Med; 2015; 35(3):214-21. PubMed ID: 26409796
[TBL] [Abstract][Full Text] [Related]
36. Association between N-acetyltransferase 2 (NAT2) genetic polymorphism and development of breast cancer in post-menopausal Chinese women in Taiwan, an area of great increase in breast cancer incidence.
Huang CS; Chern HD; Shen CY; Hsu SM; Chang KJ
Int J Cancer; 1999 Jul; 82(2):175-9. PubMed ID: 10389748
[TBL] [Abstract][Full Text] [Related]
37. NAT2 gene polymorphisms and endometriosis risk: A PRISMA-compliant meta-analysis.
Wei Z; Zhang M; Zhang X; Yi M; Xia X; Fang X
PLoS One; 2019; 14(12):e0227043. PubMed ID: 31881062
[TBL] [Abstract][Full Text] [Related]
38. N-acetyltransferase 2 polymorphism is associated with bladder cancer risk: An updated meta-analysis based on 54 case-control studies.
Song Y; Qi X; Liu X
Gene; 2020 Oct; 757():144924. PubMed ID: 32622992
[TBL] [Abstract][Full Text] [Related]
39. Association of NAT2 gene polymorphisms with susceptibility to esophageal and gastric cancers in the Kashmir Valley.
Malik MA; Upadhyay R; Modi DR; Zargar SA; Mittal B
Arch Med Res; 2009 Jul; 40(5):416-23. PubMed ID: 19766908
[TBL] [Abstract][Full Text] [Related]
40. Polymorphism of N-acetyltransferase 2 gene and the susceptibility to alcoholic liver cirrhosis: interaction with smoking.
Yang KC; Huang YS; Perng CL; Lin HC; Lee SD
Alcohol Clin Exp Res; 2011 Jul; 35(7):1204-8. PubMed ID: 21352246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
